UBS AM
LBPH

UBS AM’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

UBS AM’s Portfolio LBPH Stock Details LBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-55,079
Closed -$1.84M – 2796
2024
Q3 		$1.84M Buy
55,079
+5,023
+10% +$173K ﹤0.01% 2076
2024
Q2 		$1.35M Buy
+50,056
New +$987K ﹤0.01% 2210

UBS AM's LBPH Position: Q4 2024 in Review

UBS AM sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 55,079 shares — an estimated $1.84M sold.

UBS AM first reported a position in LBPH in Q2 2024 and held it in 2 quarters. The position peaked at $1.84M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • UBS AM reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • UBS AM sold 55,079 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $1.84M.
  • UBS AM first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
  • UBS AM's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $1.84M in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on UBS AM's 13F filing for Q4 2024, filed 14 Feb 2025.